84 related articles for article (PubMed ID: 20516430)
1. Bar the windows but open the door to randomization.
Ratain MJ
J Clin Oncol; 2010 Jul; 28(19):3104-6. PubMed ID: 20516430
[No Abstract] [Full Text] [Related]
2. Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia.
Meinhardt A; Burkhardt B; Zimmermann M; Borkhardt A; Kontny U; Klingebiel T; Berthold F; Janka-Schaub G; Klein C; Kabickova E; Klapper W; Attarbaschi A; Schrappe M; Reiter A;
J Clin Oncol; 2010 Jul; 28(19):3115-21. PubMed ID: 20516455
[TBL] [Abstract][Full Text] [Related]
3. Sixth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin lymphoma.
Weingart O; Rehan FA; Schulz H; Naumann F; Knauel I; Bohlius CB; Engert A
J Natl Cancer Inst; 2007 Sep; 99(17):E1. PubMed ID: 17728205
[No Abstract] [Full Text] [Related]
4. [Maintenance therapy with rituximab].
Krankenpfl J; 2005; 43(7-10):222-4. PubMed ID: 16515293
[No Abstract] [Full Text] [Related]
5. In focus: ECOG 4402: Rituximab Extended Schedule or Retreatment Trial (RESORT).
Clin Adv Hematol Oncol; 2004 Mar; 2(3):152. PubMed ID: 16166942
[No Abstract] [Full Text] [Related]
6. Rituximab maintenance stretches progression-free survival in patients with indolent NHL.
Oncology (Williston Park); 2004 Sep; 18(10):1316. PubMed ID: 15526836
[No Abstract] [Full Text] [Related]
7. Cisplatin versus carboplatin for patients with metastatic non-small-cell lung cancer--an old rivalry renewed.
Azzoli CG; Kris MG; Pfister DG
J Natl Cancer Inst; 2007 Jun; 99(11):828-9. PubMed ID: 17551137
[No Abstract] [Full Text] [Related]
8. New concepts in treatment approaches and prognostic factors in aggressive NHL.
Shipp M
Clin Adv Hematol Oncol; 2006 Feb; 4(2):107-9. PubMed ID: 16728917
[No Abstract] [Full Text] [Related]
9. Malignant non-Hodgkin's lymphoma of childhood and adolescence in Austria--therapy results between 1986 and 2000.
Attarbaschi A; Mann G; Dworzak M; Trebo M; Urban C; Fink FM; Horcher E; Reiter A; Riehm H; Gadner H;
Wien Klin Wochenschr; 2002 Dec; 114(23-24):978-86. PubMed ID: 12635465
[TBL] [Abstract][Full Text] [Related]
10. [Something has changed in the treatment of non-small-cell bronchogenic carcinoma in the elderly].
Portalone L; Mugnaini L
Minerva Med; 1999; 90(7-8):214-6. PubMed ID: 10719421
[No Abstract] [Full Text] [Related]
11. [Personalized, targeted treatment of non-small cell lung cancer].
Wolf J
Dtsch Med Wochenschr; 2011 Mar; 136(10):480-5. PubMed ID: 21365525
[No Abstract] [Full Text] [Related]
12. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
Collins-Burow B; Santos ES
Expert Rev Anticancer Ther; 2007 Mar; 7(3):257-73. PubMed ID: 17338647
[TBL] [Abstract][Full Text] [Related]
13. Targeted therapies in non-small-cell lung cancer: a paradigm in evolution.
Sangha R; Lara PN; Mack P; Gandara DR
Clin Lung Cancer; 2008; 9 Suppl 3():S90-1. PubMed ID: 19419929
[No Abstract] [Full Text] [Related]
14. Complete regression of cardiac non-Hodgkin lymphoma.
Morillas P; Quiles J; Nuñez D; Senent C; Martínez S; Fernández JA; Bertomeu V
Int J Cardiol; 2006 Jan; 106(3):426-7. PubMed ID: 16337063
[No Abstract] [Full Text] [Related]
15. [On ''Multimodal treatment of clinical non-small cell N2 bronchogenic carcinoma: what is the answer?''].
González Aragoneses F
Arch Bronconeumol; 2007 Mar; 43(3):183-4; author reply 184. PubMed ID: 17386198
[No Abstract] [Full Text] [Related]
16. Aggressive treatment for the fit elderly with non-small-cell lung cancer? Yes!
Sequist LV; Lynch TJ
J Clin Oncol; 2003 Sep; 21(17):3186-8. PubMed ID: 12874267
[No Abstract] [Full Text] [Related]
17. Present trends in the treatment of advanced non small-cell lung cancer.
Parvez T; Allam AR; Iskandrani A; Khan MA
J Coll Physicians Surg Pak; 2003 Aug; 13(8):483-90. PubMed ID: 12921691
[TBL] [Abstract][Full Text] [Related]
18. Platinums in lung cancer: sufficient or necessary?
Bunn PA
J Clin Oncol; 2005 May; 23(13):2882-3. PubMed ID: 15728220
[No Abstract] [Full Text] [Related]
19. Management of patients with non-Hodgkin's lymphoma.
Carbone PP
Arch Intern Med; 1973 Mar; 131(3):455-9. PubMed ID: 4569377
[No Abstract] [Full Text] [Related]
20. [Management of non-small-cell lung carcinoma (NSCLC) of stage III B].
Koukourakis M
Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S33-6. PubMed ID: 11924241
[No Abstract] [Full Text] [Related]
[Next] [New Search]
